Results 221 to 230 of about 3,152,180 (364)
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source
PSYCHOLOGICAL CHARACTERISTICS OF AUTISTIC MASKING IN ADULTS WITH AUTISM SPECTRUM DISORDER
Yu.V. Vakulenko
openalex +1 more source
RE: “PRENATAL EXPOSURE TO ACETAMINOPHEN AND RISK FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER AND AUTISTIC SPECTRUM DISORDER: A SYSTEMATIC REVIEW, META-ANALYSIS, AND META-REGRESSION ANALYSIS OF COHORT STUDIES” [PDF]
Per Damkier
openalex +1 more source
Expressive Language Development in an Autistic Bimodal Bilingual Child: A 10-Year Case Study. [PDF]
Shield A, Cardamone K.
europepmc +1 more source
Establishing a Translational Science for Autistic Spectrum Disorders for Children and Their Families: Optimizing Function, Participation, and Well-Being [PDF]
Michael E. Msall
openalex +1 more source
Breaking with the Criteria; Selective Mutism and its Forbidden Connection with Autism. [PDF]
Helgesen I, Nordahl-Hansen A.
europepmc +1 more source
Abstract Objective Addressing the poorly understood impact of pediatric epilepsy on neurodevelopment, this large‐scale study delineates age‐ and sex‐stratified neurostructural trajectories in magnetic resonance imaging (MRI)‐negative pediatric epilepsy to identify periods of maximal developmental divergence from healthy controls.
Yingfan Wang +10 more
wiley +1 more source
An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder
C. Erickson +5 more
semanticscholar +1 more source

